© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#bladder cancer

Keytruda Improves Long-Term Survival for People With Bladder Cancer
Treating Cancer No Matter Where It Occurs
Bladder Cancer 101
Nektar Therapeutics headquarters in San Francisco

Novel Immunotherapy Combo Shrinks Bladder Tumors

NKTR-214 plus Opdivo as first-line therapy had an overall response rate of 48 percent.

Cancer Medications

Keytruda

T cells attack a cancer cell

What’s New in Treatment for Advanced Bladder Cancer?

A new area of research is examining the use of checkpoint inhibitors before surgery, a practice known as neoadjuvant therapy.

TICE

Imfinzi

Bavencio

Tecentriq (atezolizumab)

Tecentriq

Opdivo

FDA Updates Prescribing Information for Keytruda and Tecentriq

Requires use of diagnostic tests for PD-L1 levels in tumor tissue from bladder cancer patients.

FDA Limits Use of Tecentriq and Keytruda for Some Urothelial Cancer Patients

Decreased survival seen in some metastatic bladder cancer patients treated with pembrolizumab or atezolizumab monotherapy.

New Treatment Approach Could Help Prevent Recurrences of Some Bladder Cancers

Researchers say adopting the treatment “could spare patients a lot of suffering from repeated surgeries and save health care costs.”

Bladder Cancer Awareness Month

May is Bladder Cancer Awareness Month.

Those Treated With Newer Hep C Drugs Have Lower Non-Liver Cancer Rates

The link between the older interferon treatment and these cancers may be related to the drug’s low hep C cure rate.
Robert Jones at GU18

GU18: Prostate, Bladder, Kidney and All Things Genitourinary

Are immunotherapy and targeted therapies ready to replace toxic chemotherapy?
Gut bacteria

Gut Bacteria May Improve Effectiveness of Immunotherapy

Certain types of bacteria were associated with greater disease progression while others were linked to improved survival.
Advertisement
Treatment News
Newsfeed